Nova Patents
IL260400B2

Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

26 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
201662276700United States of AmericaP
201662404638United States of AmericaP
2017012496United States of AmericaW

Members26

Family members, oldest first
DocumentOfficeKind
CA3010801A1CanadaA1
US2017199193A1United States of AmericaA1
WO2017120446A1World Intellectual Property Organization (WIPO)A1
AU2017205170A1AustraliaA1
KR20180095094ARepublic of KoreaA
IL260400AIsraelA
EP3399980A1European Patent Office (EPO)A1
JP2019504063AJapanA
EP3399980A4European Patent Office (EPO)A4
MX2018008421AMexicoA
US10648983B2United States of AmericaB2
US2020333340A1United States of AmericaA1
JP6880037B2JapanB2
AU2017205170B2AustraliaB2
JP2021121799AJapanA
JP7113942B2JapanB2
IL260400BIsraelB
US11460471B2United States of AmericaB2
IL296659AIsraelA
JP2022166014AJapanA
IL260400B2This recordIsraelB2
US2023064156A1United States of AmericaA1
MX390772BMexicoB
EP3399980B1European Patent Office (EPO)B1
US12474342B2United States of AmericaB2
ES3042541T3SpainT3